TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive DCE Board Approves Concept For New $850,000 Year Grant Program To Study Viruses In Cervical Cancer November 9, 1984